Laserscope Sets Niagara BPH System Annual Sales Target Of $90 Mil. By 2006
This article was originally published in The Gray Sheet
Executive Summary
Laserscope aims to generate up to $90 mil. in annual sales of its Niagara PVP laser treatment system for benign prostatic hyperplasia (BPH) by 2006